Mindfulness Based Relapse Prevention: Clinical Trials

11 trials of Mindfulness Based Relapse Prevention, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed, 3 recruiting, 1 suspended. 9 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable9Completed 6, Recruiting 3
Phase 11Completed 1
Phase 21Completed 1
Phase 31Suspended 1

Follow Mindfulness Based Relapse Prevention: new trials by email Literature Review of Mindfulness Based Relapse Prevention trials Research Report on Mindfulness Based Relapse Prevention

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Mindfulness-based Relapse Prevention for Peer Workers
Mindfulness Based Relapse Prevention, Standard of Care - Relapse/Recurrence, Substance Use (Drugs, Alcohol)
Not applicableRecruitingUniversity of Texas at Austin802026-08-012026-08-07
Wellness, Alcohol, Vitals, and Emotions
Mindfulness based relapse prevention - Alcohol Use
Not applicableRecruitingUniversity of New Mexico1202025-10-012026-07-15
Comparison of the Effectiveness of Two Psycho-physical Interventions: Mindfulness Based Relapse Prevention (MBRP) and Unguided Meditative Relaxation in Patients With Alcohol Use Disorder
Mindfulness Based Relapse Prevention, Relaxation/ meditation - Alcohol Use Disorder (AUD)
Not applicableRecruitingCentre Hospitalier Universitaire de Nīmes1682021-10-202025-08-21
Mindfulness-Based Relapse Prevention for Opioid and Alcohol Use Disorders
Mindfulness Based Relapse Prevention - Opioid-use Disorder, Opioid Abuse, in Remission
Not applicableCompletedClemson University112020-07-012024-03-08
Mindfulness for at Risk Youth: Understanding Substance Use and Important Mechanisms of Change
Mindfulness Based Relapse Prevention, Control (CTL) - Alcohol Use, Underage, Alcohol Problem Drinking
Not applicableCompletedUniversity of Southern California242019-03-052021-09-29
Neurocognitive and Neurobehavioral Mechanisms of Change Following Psychological Treatment for Alcohol Use Disorder
Cognitive Behavior Therapy, Mindfulness Based Relapse Prevention - Alcohol Use Disorder, Alcohol Abuse
Not applicableCompletedUniversity of New Mexico1102018-11-142025-04-22
Glutamatergic Modulation to Facilitate the Behavioral Treatment of Cocaine Use Disorders
CI-581a, CI-581b, Motivational Enhancement Therapy (MET) - Cocaine Use Disorder
Phase 3SuspendedNew York State Psychiatric Institute1502017-10-012024-07-16
Effectiveness of Mindfulness Based Relapse Prevention for Tobacco Dependents
Mindfulness Based Relapse Prevention, Brazilian Ministry of Health Protocol - Tobacco Use Disorder
Not applicableCompletedFederal University of São Paulo602012-10-012020-07-27
Mindfulness-Based Relapse Prevention for Alcohol Use Disorders in Remission
Mindfulness Based Relapse Prevention, Treatment as usual - Alcohol Use Disorders
Not applicableCompletedUniversity of Virginia42012-08-012019-04-17
Mindfulness Based Relapse Prevention for Stimulant Users
Mindfulness Based Relapse Prevention, Health Education - Stimulant Dependence
Not applicableCompletedUniversity of California, Los Angeles622010-04-012022-04-29
Mindfulness Based Relapse Prevention: Efficacy and Mechanisms
Mindfulness Based Relapse Prevention, Relapse Prevention, Treatment as Usual - Substance Use Disorders
Phase 1 / Phase 2CompletedUniversity of Washington2862009-10-012016-08-15

Conditions studied

Alcoholism (5)  ·  Substance-Related Disorders (3)  ·  Alcohol Drinking (2)  ·  Behavior, Addictive (2)  ·  Burnout, Psychological (1)  ·  Emotional Regulation (1)  ·  Harm Reduction (1)  ·  Impulsive Behavior (1)  ·  Occupational Stress (1)  ·  Opioid-Related Disorders (1)  ·  Recurrence (1)  ·  Tobacco Use Disorder (1)  ·  Underage Drinking (1)  ·  Wounds and Injuries (1)

Sponsors

University of New Mexico (2)  ·  Centre Hospitalier Universitaire de Nīmes (1)  ·  Clemson University (1)  ·  Federal University of São Paulo (1)  ·  New York State Psychiatric Institute (1)  ·  University of California, Los Angeles (1)  ·  University of Southern California (1)  ·  University of Texas at Austin (1)  ·  University of Virginia (1)  ·  University of Washington (1)

Countries

United States (9)  ·  Brazil (1)  ·  France (1)

Top investigators

Amandine Luquiens (1)  ·  Ana Regina Noto, Doctor (1)  ·  Barbara McCrady, PhD (1)  ·  Elias Dakwar, MD (1)  ·  Jennifer K Penberthy, PhD (1)  ·  Lu Shi, Ph.D. (1)  ·  Matison W McCool, Phd (1)  ·  Sarah Bowen, PhD (1)  ·  Suzette Glasner, Ph.D. (1)

Results publications

PMID 24647726, PMID 31304887, PMID 32222767, PMID 35420700

NIH funding

K01DA065810 (1), K23AA031729 (1), R01DA025764 (1), U01DA040647 (1)